FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tacrolimus from Sandoz Inc. The approval enables the marketing of a generic tacrolimus product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)